lansoprazole has been researched along with Hypertrophy in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
Excerpt | Relevance | Reference |
---|---|---|
"The aim of the present study was to investigate whether not only omeprazole but also lansoprazole leads to hypertrophy of the parietal cells of the gastric mucosa." | 9.09 | Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach. ( Alexandridis, T; Meining, A; Seifert, E; Stolte, M, 2000) |
"The aim of the present study was to investigate whether not only omeprazole but also lansoprazole leads to hypertrophy of the parietal cells of the gastric mucosa." | 5.09 | Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach. ( Alexandridis, T; Meining, A; Seifert, E; Stolte, M, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, RK | 1 |
Simpson, CB | 1 |
Velazquez, R | 1 |
Larson, N | 1 |
Stolte, M | 1 |
Meining, A | 1 |
Seifert, E | 1 |
Alexandridis, T | 1 |
1 trial available for lansoprazole and Hypertrophy
Article | Year |
---|---|
Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Cell Count; Double-Blind Method; Female; | 2000 |
1 other study available for lansoprazole and Hypertrophy
Article | Year |
---|---|
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2004 |